Výsledky vyhledávání - "Rui L, Avelar"

The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients

Autor: Vernon Leroy Young, Brian S. Biesman, Corey S. Maas, Mary P. Lupo, John E. Gross, Joel Schlessinger, Ava Teresa Shamban, Susan H Weinkle, Rui L Avelar, Hema Sundaram, Zoe Diana Draelos, Derek H. Jones, Joely Kaufman-Janette

Publikováno v: Aesthetic Surgery Journal

Background PrabotulinumtoxinA is a 900-kDa botulinum toxin type A produced by Clostridium botulinum. Objectives The authors sought to investigate the safety of prabotulinumtoxinA for treatment of glabellar lines. Methods This was a multicenter, open-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::870bbac212779e5297f556e0310bee68
https://doi.org/10.1093/asj/sjaa383

Zobrazit plný text záznamu

PrabotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Patients With Skin of Color: Post Hoc Analyses of the US Phase III Clinical Study Data

Autor: John H Joseph, Rui L Avelar, Anneke Jonker, Pearl E. Grimes, Susan C. Taylor

Publikováno v: Dermatologic Surgery

Background Limited US clinical data are available on the use of aesthetic products in patients with skin of color (SOC). Objective To compare the efficacy and safety of prabotulinumtoxinA for the treatment of glabellar lines in patients with and with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86f184ee449ab56607c448a91bd4940f
https://doi.org/10.1097/dss.0000000000002864

Zobrazit plný text záznamu

Efficacy and Safety of PrabotulinumtoxinA for the Treatment of Glabellar Lines in Adult Subjects: Results From 2 Identical Phase III Studies

Autor: John E. Gross, Anneke Jonker, Ava Shamban, Rui L Avelar, Kenneth Beer

Publikováno v: Dermatologic Surgery

Supplemental Digital Content is Available in the Text.
BACKGROUND PrabotulinumtoxinA is a 900-kDa botulinum toxin Type A produced by Clostridium botulinum. OBJECTIVE To investigate the efficacy and safety of prabotulinumtoxinA for the treatment

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57e7cc0e488684688f1a16585e32fbb9
https://doi.org/10.1097/dss.0000000000001903

Zobrazit plný text záznamu

Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients

Autor: Joely Kaufman-Janette, Rui L Avelar, Brian S Biesman, Zoe Diana Draelos, John E Gross, Derek H Jones, Mary P Lupo, Corey S Maas, Joel Schlessinger, Ava Teresa Shamban, Hema Sundaram, Susan H Weinkle, Vernon L Young

Publikováno v: Aesthetic Surgery Journal

PrabotulinumtoxinA is a 900-kDa botulinum toxin type A produced by Clostridium botulinum.The authors sought to investigate the safety of prabotulinumtoxinA for treatment of glabellar lines.This was a multicenter, open-label, repeat-dose, 1-year phase

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cf040c02ce5648cad49ac85f96dde5d
http://europepmc.org/articles/PMC8598191

Zobrazit plný text záznamu

Relationship between delayed reactions to dermal fillers and biofilms: facts and considerations

Autor: Rui L Avelar, Kenneth Beer

Publikováno v: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 40(11)

BACKGROUND: Delayed reactions associated with dermal fillers have often been attributed to hypersensitivity reactions; however, the evolving literature suggests that biofilms may represent an underrecognized cause and a difficult diagnosis to establi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb2f23427bd15eed43fd8fe3a979aafe
https://pubmed.ncbi.nlm.nih.gov/25322166

Zobrazit plný text záznamu

The safety and effectiveness of the retrievable option inferior vena cava filter: a United States prospective multicenter clinical study

Autor: Michael S. Stecker, Anthony C. Venbrux, James F. Benenati, Dirk S. Baumann, Mark J. Garcia, Matthew S. Johnson, John A. Kaufman, Ziv J Haskal, Bart Dolmatch, Rui L. Avelar, Albert A. Nemcek

Publikováno v: Journal of vascular and interventional radiology : JVIR. 21(8)

Purpose To evaluate the safety and effectiveness of the retrievable Option inferior vena cava (IVC) filter in patients at risk for pulmonary embolism (PE). Materials and Methods This was a prospective, multicenter, single-arm clinical trial. Subjects

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::043de32c968bf2bff2a660c6ccb81c01
https://pubmed.ncbi.nlm.nih.gov/20598570

Zobrazit plný text záznamu

Inhibition of neointimal hyperplasia in a sheep model of dialysis access failure with the bioabsorbable Vascular Wrap paclitaxel-eluting mesh

Autor: Ted R, Kohler, Philip M, Toleikis, David M, Gravett, Rui L, Avelar

Publikováno v: Journal of vascular surgery. 45(5)

This study evaluated the effect of a bioabsorbable mesh containing paclitaxel on neointimal hyperplasia in a sheep model of dialysis access failure.Forty neutered male sheep were randomized to one of five parallel groups: no mesh; or a 3-cm x 6-cm me

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6b2245f0a5b22e3bf4aece25abc82b4d
https://pubmed.ncbi.nlm.nih.gov/17466798

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání